Overview
Balance Sheet
Cash Flow
Growth Analysis
2023
2022
2021
2020
2019
Profitability Metrics
Gross Margin
48.68%
Operating Margin
9.20%
Net Margin
0.85%
Efficiency Metrics
Revenue per Expense Ratio
1.11
R&D as % of Revenue
0.00%
Earnings Quality
EBITDA Margin
29.29%
Income Tax Rate
0.00%
EPS
-0.1100000000
Balance Sheet Analysis
Current Ratio
2.60
Cash Ratio
1.97
Working Capital
$55.46M
Debt to Equity
0.65
Debt to Assets
37.57%
Equity Ratio
57.75%
Cash Flow Analysis
Operating Cash Flow Ratio
24.57%
Free Cash Flow Ratio
15.53%
CapEx to Revenue
9.04%
Dividends Paid
$22.16M
Stock Buybacks
$172.93M
Total Shareholder Returns
$195.09M
Cash Position Change
89.91%
Key Takeaways (2023 FY)
Maintained positive net income growth despite revenue changes
Increased dividend payments by 173.42%
Detailed Growth Metrics
Core Performance
Revenue
5.51%
Net Income
115.76%
EPS
67.65%
Operating Income
-21.50%
Operational Efficiency
R&D Expenses
-100.00%
SG&A Expenses
1.03%
Operating Cash Flow
6.86%
Free Cash Flow
36.82%
Balance Sheet Health
Assets
0.01%
Debt
2.62%
Book Value per Share
-1.77%
Inventory
100.00%
Shareholder Returns
Dividends per Share
173.42%
Shares Outstanding
0.11%
Long Term Trends
3Y Revenue/Share
106.39%
5Y Revenue/Share
-9.50%
3Y Dividend/Share
31.22%
5Y Dividend/Share
-66.06%